GO
Loading...

Celgene Corp

More

  • Midday Glance: Biotechnology companies Thursday, 23 Oct 2014 | 1:51 PM ET

    Amgen Inc. rose $3.75 or 2.6 percent, to $147.39. Biogen Idec rose $7.67 or 2.5 percent, to $316.74. Celgene Corp. rose $5.82 or 6.1 percent, to $100.58.

  • Early Glance: Biotechnology companies Thursday, 23 Oct 2014 | 11:56 AM ET

    Amgen Inc. rose $3.58 or 2.5 percent, to $147.22. Biogen Idec rose $4.73 or 1.5 percent, to $313.80. Celgene Corp. rose $2.67 or 2.8 percent, to $97.43.

  • Celgene 3Q profit climbs; company lifts outlook Thursday, 23 Oct 2014 | 7:54 AM ET

    NEW YORK— Celgene Corp. said Thursday that its net income climbed 37 percent in the third quarter, and the biotechnology company raised its forecast for the full year. Celgene also announced a new cancer drug development partnership with a price tag that could top $1 billion. Excluding one-time items Celgene said it earned 97 cents per share.

  • Final Glance: Biotechnology companies Wednesday, 22 Oct 2014 | 6:09 PM ET

    Amgen Inc. fell$. 45 or. 3 percent, to $143.64. Biogen Idec fell $17.70 or 5.4 percent, to $309.07. Celgene Corp. fell$. 21 or. 2 percent, to $94.76.

  • Midday Glance: Biotechnology companies Wednesday, 22 Oct 2014 | 1:18 PM ET

    Amgen Inc. fell $1.59 or 1.1 percent, to $142.50. Biogen Idec fell $23.54 or 7.2 percent, to $303.23. Celgene Corp. fell$. 60 or. 6 percent, to $94.37.

  • Early Glance: Biotechnology companies Wednesday, 22 Oct 2014 | 10:36 AM ET

    Amgen Inc. fell $1.16 or. 8 percent, to $142.93. Biogen Idec fell $21.61 or 6.6 percent, to $305.16. Celgene Corp. rose $1.23 or 1.3 percent, to $96.20.

  • Final Glance: Biotechnology companies Tuesday, 21 Oct 2014 | 6:01 PM ET

    Amgen Inc. rose $6.58 or 4.8 percent, to $144.09. Biogen Idec rose $15.36 or 4.9 percent, to $326.77. Celgene Corp. rose $2.97 or 3.2 percent, to $94.97.

  • Midday Glance: Biotechnology companies Tuesday, 21 Oct 2014 | 1:43 PM ET

    Amgen Inc. rose $1.96 or 1.4 percent, to $139.47. Biogen Idec rose $8.12 or 2.6 percent, to $319.53. Celgene Corp. rose $2.57 or 2.8 percent, to $94.57.

  • Early Glance: Biotechnology companies Tuesday, 21 Oct 2014 | 11:56 AM ET

    Amgen Inc. rose $1.55 or 1.1 percent, to $139.06. Biogen Idec rose $6.48 or 2.1 percent, to $317.89. Celgene Corp. rose $3.34 or 3.6 percent, to $95.34.

  • Final Glance: Biotechnology companies Monday, 20 Oct 2014 | 6:05 PM ET

    Amgen Inc. rose $3.82 or 2.9 percent, to $137.51. Biogen Idec rose $4.70 or 1.5 percent, to $311.41. Celgene Corp. rose $3.88 or 4.4 percent, to $92.00.

  • *IBM slumps after quarterly results. NEW YORK, Oct 20- U.S. stocks ended higher on Monday on investor hopes for a strong earnings season, but IBM's disappointing results limited gains. IBM shares slumped 7.1 percent to $169.10, the biggest drag on both the Dow and S&P 500, after third-quarter earnings fell well short of Wall Street expectations.

  • Midday Glance: Biotechnology companies Monday, 20 Oct 2014 | 1:23 PM ET

    Amgen Inc. rose$. 35 or. 3 percent, to $134.04. Biogen Idec rose $3.41 or 1.1 percent, to $310.12. Celgene Corp. rose $3.24 or 3.7 percent, to $91.36.

  • Early Glance: Biotechnology companies Monday, 20 Oct 2014 | 10:40 AM ET

    Amgen Inc. rose$. 93 or. 7 percent, to $134.62. Biogen Idec rose $2.07 or. 7 percent, to $308.78. Celgene Corp. rose $1.72 or 2.0 percent, to $89.84.

  • Final Glance: Biotechnology companies Friday, 17 Oct 2014 | 6:03 PM ET

    Amgen Inc. rose $3.24 or 2.5 percent, to $133.69. Biogen Idec rose $3.97 or 1.3 percent, to $306.71. Celgene Corp. rose $1.74 or 2.0 percent, to $88.12.

  • Midday Glance: Biotechnology companies Friday, 17 Oct 2014 | 1:21 PM ET

    Amgen Inc. rose $3.30 or 2.5 percent, to $133.75. Biogen Idec rose $9.17 or 3.0 percent, to $311.91. Celgene Corp. rose $3.04 or 3.5 percent, to $89.42.

  • Early Glance: Biotechnology companies Friday, 17 Oct 2014 | 10:39 AM ET

    Amgen Inc. rose$. 25 or. 2 percent, to $130.70. Biogen Idec rose $8.00 or 2.6 percent, to $310.74. Celgene Corp. rose $2.45 or 2.8 percent, to $88.83.

  • Final Glance: Biotechnology companies Thursday, 16 Oct 2014 | 6:02 PM ET

    Amgen Inc. fell$. 45 or. 3 percent, to $130.45. Biogen Idec fell $2.95 or 1.0 percent, to $302.74. Celgene Corp. fell$. 17 or. 2 percent, to $86.38.

  • Midday Glance: Biotechnology companies Thursday, 16 Oct 2014 | 1:21 PM ET

    Amgen Inc. fell $1.85 or 1.4 percent, to $129.05. Biogen Idec fell $2.23 or. 7 percent, to $303.46. Celgene Corp. fell$. 18 or. 2 percent, to $86.37.

  • Early Glance: Biotechnology companies Thursday, 16 Oct 2014 | 11:35 AM ET

    Amgen Inc. fell $1.81 or 1.4 percent, to $129.09. Biogen Idec fell $2.69 or. 9 percent, to $303.00. Celgene Corp. fell $1.56 or 1.8 percent, to $84.99.

  • Final Glance: Biotechnology companies Wednesday, 15 Oct 2014 | 6:07 PM ET

    Amgen Inc. fell $1.30 or 1.0 percent, to $130.90. Biogen Idec rose $4.11 or 1.4 percent, to $305.69. Celgene Corp. rose$. 07 or. 1 percent, to $86.55.